EBS – emergent biosolutions inc. (US:NASDAQ)
Stock Stats
News
Emergent BioSolutions Inc. (NYSE: EBS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) [Yahoo! Finance]
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Why Emergent BioSciences Stock Plummeted Today [Yahoo! Finance]
Form 4 Emergent BioSolutions For: Dec 15 Filed by: Lowry Simon C
Form 4 Emergent BioSolutions For: Dec 08 Filed by: Glessner Coleen
Form EFFECT Emergent BioSolutions
Form 424B3 Emergent BioSolutions
Form S-1/A Emergent BioSolutions
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.